Melbourne-based healthtech business Heidi Health has raised $65 million in a Series B investment headed by Steve Cohen’s Point72 Private Investments. Therefore, marking a major accomplishment in its efforts to simplify clinical processes using artificial intelligence.
Heidi’s valuation is now about $465 million thanks to this cash infusion, bringing her total capital raised to around $100 million. Among the round’s participants were already supporting companies Blackbird, Headline, and Latitude. Heidi Health creates an artificial intelligence-powered ‘Care Partner’ to act as a medical scribe managing administrative burdens that frequently weigh heavily on doctors. Its feature set includes:
Converting patient consultations in more than 110 languages
Creating organized clinical notes and summaries
Dealing with follow-up correspondence chores
Automatic coding, referrals, and output integration with electronic health record (EHR) systems.
Through use in over 70 million patient visits spanning 116 countries, the startup claims it has already returned more than 18 million hours to frontline AI in healthcare providers. Heidi presented important additions to its executive team along with the money announcement. Paul Williamson, formerly head of revenue at Plaid, joins as Chief Revenue Officer; And Dr Simon Kos , formerly Chief Medical Officer at Microsoft, starts Heidi’s Chief Medical Officer position. With the new funds, the corporation plans to accelerate global operations, improve regional support over key markets including the U.S., UK, and Canada, and grow product development.
Further growth is intended in Asia, Europe (France, Germany, Spain, Ireland), and other countries. Heidi’s struggle is converting promise into dependability, especially in a field where errors have actual effects. AI scribe companies like Suki, Ambience Healthcare, Tandem Health, and others are among its competitors. Using its own artificial intelligence in conjunction with external models such as Google’s AI Plus , the company’s model-agnostic strategy seeks to maximize cost, latency, and accuracy trade-offs. The fundraising round sets Heidi Health among the rising frontrunners in AI-enabled clinical documentation.